Press release
The Rising Prevalence Of Cancer Driving Growth In The Keytruda Market: An Emerging Driver Transforming The Keytruda Market Landscape
Keytruda
What Is the Projected Growth of the Keytruda Market?
The Keytruda market is projected to grow from $21.6 billion in 2024 to $23.8 billion in 2025, at a CAGR of 10.2%. This growth is driven by improved patient outcomes, the adoption of immunotherapy, advancements in research and development, and better patient compliance.
The Keytruda market is projected to experience strong growth, expected to reach $34.61 billion by 2029 at a CAGR of 9.8%. The growth is attributed to expanding indications, emerging markets, rising cancer prevalence, increasing healthcare expenditure, and the growing demand for precision medicine. Major trends include demand for targeted therapies, advancements in immunotherapy, diagnostic technology innovations, increased cancer treatment demand, and progress in cancer research.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16457
What Are the Different Keytruda Market Segments?
The keytruda market covered in this report is segmented -
1) By Cancer Type: Melanoma, Lung Cancer, Head And Neck Cancer, Hodgkin Lymphoma, Stomach Cancer, Urothelial Carcinoma
2) By Payer Type: Commercial, Medicare, Medicaid
3) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies
Subsegments:
1) By Melanoma: Advanced Or Unresectable Melanoma, Adjuvant Treatment For Melanoma
2) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)
3) By Head And Neck Cancer: Squamous Cell Carcinoma Of The Head And Neck (SCCHN), Recurrent Or Metastatic Head And Neck Cancer
4) By Hodgkin Lymphoma: Classical Hodgkin Lymphoma, Relapsed Or Refractory Hodgkin Lymphoma
5) By Stomach Cancer: Advanced Or Metastatic Gastric Cancer, Esophagogastric Junction Cancer
6) By Urothelial Carcinoma: Advanced Or Metastatic Urothelial Carcinoma, Muscle-Invasive Bladder Cancer
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16457&type=smp
What Are the Primary Drivers Shaping the Keytruda Market?
The increasing prevalence of cancer is expected to drive the growth of the Keytruda market. Cancer involves the abnormal growth and spread of cells and is influenced by genetic, lifestyle, environmental, and hormonal factors. Keytruda (pembrolizumab) is an immune checkpoint inhibitor used in cancer treatment, harnessing the body's immune system to fight cancer cells. This has provided new hope for patients with advanced cancers. In January 2024, the American Cancer Society reported 2,001,140 cancer cases in 2024, a 2.19% increase from 1,958,310 cases in 2023. The increasing prevalence of cancer is thus driving the Keytruda market.
Which Companies Are Leading in the Keytruda Market?
Major companies operating in the keytruda market are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Novartis AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Chugai Pharmaceutical Co. Ltd., BioNTech AG, Organon Co., Ono Pharmaceutical Co. Ltd., Samsung Bioepis Co. Ltd., Fate Therapeutics Inc., Merck Sharp & Dohme Corp., KinBio, Schering-Plough AB, LGM Pharma LLC, Gritstone Bio Inc.
What Trends Are Expected to Dominate the Keytruda Market in the Next 5 Years?
Key players in the Keytruda market, such as Merck, are creating innovative products like pembrolizumab, boosting the availability of treatment choices. Pembrolizumab is a type of drug classified as immune checkpoint inhibitors and is a monoclonal antibody medicine. The brand name under which it is marketed is Keytruda. It functions by targeting and obstructing the PD-1 (programmed cell death protein 1) protein on immune cells termed T cells. For instance, in November 2023, Merck, a US-based Keytruda manufacturer, introduced KEYTRUDA (pembrolizumab) used in combination with a fluoropyrimidine- and platinum-based chemotherapy, which gained approval from the Food and Drug Administration, an agency of the US government. This combination has exhibited considerable enhancements in both overall survival and progression-free survival rates compared to single-use chemotherapy, making it a significant step forward in gastric cancer treatment. Throughout clinical trials, this combined therapy has shown improvements in overall survival (OS), progression-free survival (PFS), and overall response rate (ORR) than using chemotherapy as a solitary treatment.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/keytruda-global-market-report
What Are the Top Revenue-Generating Geographies in the Keytruda Market?
North America was the largest region in the keytruda market in 2023. The regions covered in the keytruda market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Keytruda Market?
2. What is the CAGR expected in the Keytruda Market?
3. What Are the Key Innovations Transforming the Keytruda Industry?
4. Which Region Is Leading the Keytruda Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Rising Prevalence Of Cancer Driving Growth In The Keytruda Market: An Emerging Driver Transforming The Keytruda Market Landscape here
News-ID: 4042319 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Key
Caprylyl Glycine Market Size, Share and Forecast By Key Players-Key Player I, Ke …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Caprylyl Glycine market is anticipated to grow at a compound annual growth rate (CAGR) of 16.41% between 2024 and 2031. The market is expected to grow to USD 11.09 Billion by 2024. The valuation is expected to reach USD 32.12 Billion by 2031.
The Caprylyl Glycine market is experiencing significant growth, driven by its increasing demand in the…
Polyurethane Prepolymer (PPU) Market Size, Share and Forecast By Key Players-Key …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Polyurethane Prepolymer (PPU) market is anticipated to grow at a compound annual growth rate (CAGR) of 11.68% between 2024 and 2031. The market is expected to grow to USD 8.1 Billion by 2024. The valuation is expected to reach USD 17.54 Billion by 2031.
The Polyurethane Prepolymer (PPU) Market is set for significant growth, driven by increasing demand…
Olivine Sand Market Size, Share and Forecast By Key Players-Key Player I, Key Pl …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Olivine Sand market is anticipated to grow at a compound annual growth rate (CAGR) of 16.07% between 2024 and 2031. The market is expected to grow to USD 39 Billion by 2024. The valuation is expected to reach USD 110.69 Billion by 2031.
The olivine sand market is poised for significant growth due to its increasing use in…
Phlorotannins Market Analysis By Top Keyplayers - Key Player I, Key Player II, K …
The "Phlorotannins Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Phlorotannins Market, 2024-2031
Verified Market Research's most recent report, "Phlorotannins Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
Direct Drive Frameless Motor Market Size, Insights 2031 by Key Vendors- Key Play …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global Direct Drive Frameless Motor Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a 𝐂𝐀𝐆𝐑 𝐗𝐗.𝐗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏.
The Direct Drive Frameless Motor Market presents significant opportunities for growth driven by advancements in technology and the increasing demand for high-performance, precision-driven applications across various industries.…
Hydroxylamine Hcl Market Size, Share Projections 2031 by Key Manufacturer- Key P …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global Hydroxylamine Hcl Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a 𝐂𝐀𝐆𝐑 𝐗𝐗.𝐗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏.
The Hydroxylamine HCl Market offers substantial opportunities for growth driven by its diverse applications across various industries. Hydroxylamine hydrochloride is widely used as a reducing agent in chemical synthesis,…
